| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 283.44 | 3.4% | 2.4% |
| Total Income | 283.44 | 3.4% | 2.4% |
| Expenditure | 200.95 | 3.4% | 1.3% |
| PBT | — | ||
| Net Profit | 46.70 | 10.6% | 23.5% |
| OPM | 29.10% | 0.04pp | 2.57pp |
| NPM | 16.48% | 1.08pp | 4.55pp |
| EPS | 0.98 | 13.9% | 20.3% |
Prestige Consumer Healthcare Announces Q3 2026 Results
04 May 2026 · 4 May, 1:25 am
Summary
Prestige Consumer Healthcare Inc. announced its financial results for the fiscal quarter and nine months ended December 31, 2025, on February 5, 2026. The company communicated these results through a press release and investor presentations. The investor presentations were made using slides attached to a Current Report on Form 8-K. The company may use these presentations, with modifications, in future presentations to investors and analysts.
Key Highlights
- 1
Prestige Consumer Healthcare Inc. announced financial results for the fiscal quarter and nine months ended December 31, 2025.
- 2
The announcement was made via a press release on February 5, 2026.
- 3
The company also began making presentations to investors regarding the financial results for the quarter and nine months ended December 31, 2025.
- 4
These presentations used slides attached to a Current Report on Form 8-K as Exhibit 99.2.
Informational and educational content only. Not investment advice.